Please login to the form below

Not currently logged in


This page shows the latest risdiplam news and features for those working in and with pharma, biotech and healthcare.

EU authorises Roche’s spinal muscular atrophy treatment Evrysdi

EU authorises Roche’s spinal muscular atrophy treatment Evrysdi

The EC has approved Evrysdi (risdiplam) for the treatment of SMA in patients aged two months or older who have a clinical diagnosis of SMA type 1, type 2, type 3

Latest news

More from news
Approximately 6 fully matching, plus 18 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...